We are pleased to announce that our portfolio company, Chordia Therapeutics Inc., has been newly listed on the TSE Growth Market on June 14, 2024.
Chordia Therapeutics Inc. is a drug discovery company focused on the research and development of innovative anti-cancer drugs. Leveraging the extensive experience and specialized skills of professionals who have been involved in drug discovery for many years, the company is dedicated to developing new drugs that will shape the future of cancer treatment.
For more details on Chordia Therapeutics Inc.'s listing, please refer to the press release linked below:
Press Release on Chordia Therapeutics Inc.'s Listing
For investor relations information, please visit the following website: